Master The Market with the Help of Our Financial Experts
Recent Articles from TheStreet
5 Top Stock Gainers for Tuesday: ImmunoGen, Immunity Bio, Navigator
ImmunoGen, ImmunityBio, Navigator Holdings, Identiv and Citi Trends are five top stock gainers for Tuesday.
Wedbush Bullish on Redbox Entertainment, Starts Coverage at Outperform
Redbox can capitalize on its DVD watching loyal customer base to switch to digital and easily clock $1 billion in revenue, said Wedbush.
Samsung Launches New Auto Chip For Volkswagen, Other Cars
Samsung Electronics announced that it is making three advanced chips tailored specifically for cars.
Didi Delisting May Hold Silver Lining for IPO Investors
Crackdown by Beijing on tech companies continues to ramp up.
Chico's Stock Firms on Unexpected Third-Quarter Profit
Chico's net income registered 15 cents a share in the quarter, obliterating the FactSet analyst consensus of a 3-cent loss.
NLS Pharmaceutics Soars on Long Covid Fatigue Test Results
NLS says testing of Lauflumide 'offers promise to become a foundational treatment' for Long Covid.
Nio Stock Drops After Panning Europe Factory Expansion Plans
Nio stock falls after the Chinese luxury electric vehicle maker denies reports that it plans to establish a factory in Europe as part of its expansion plans.
S&P 500 Should Hit 5,000 in First-Half 2022: JPMorgan
'Global supply chain pressures are easing,' JPMorgan says. 'If this persists, the S&P 500 should continue to deliver ... record margins.'
AstraZeneca Gains Priorty FDA Review for Breast Cancer Drug
Pharmaceutical titan AstraZeneca announces the FDA has granted priority review for its drug Lynparza used to treat breast cancer after chemotherapy.